Acta Biochimica et Biophysica SinicaBiochemistryPeer-reviewed journal article
Gut microbiota and bile acids changes in MASLD mice model with hepatic PLD1 knockout
Yushang Zhao, Huan WangiD, Wanling LiniD, Hui WangiD, Linlin CaoiD
Abstract
Hepatocyte phospholipase D1 (PLD1) knockout alleviated metabolic dysfunction-associated steatotic liver disease (MASLD) in mice, but the underlying mechanism is largely unknown. In this study, high-fat diet is fed to wild type (Con) and hepatocyte PLD1 knockout (Con_KO) mice to establish MASLD model (HFHC and HFHC_KO). Intestinal contents of mice are analyzed via metagenomics and metabolomics, the liver bile acids are assessed by mass spectrometry imaging. At phylum level, Bacillota in the intestines of MASLD model mice are significantly increased and Bacteroidota are significantly decreased. However, after the deletion of hepatocyte PLD1, Pseudomonadota and Candidatus Bathyarchaeota are significantly decreased in the MASLD model mice. Then at species level, compared with Con group, the Faecalibaculum rodentium is significantly increased in HFHC group, in which hepatocyte PLD1 knockout causes Desulfovibrionaceae bacterium LT0009 and Lachnospiraceae bacterium 10-1 to significantly decrease. As for intestinal bile acids, two bile acids (Hyodeoxycholic acid and Glycolithocholic acid) are found to be different between the HFHC_KO group and the HFHC group. Association analysis shows the Faecalibaculum co-occurs with DCA, {beta}MCA, {Omega}MCA and MCA, while probiotic Bacteroides uniformis is significantly correlated with UDCA, 12-KetoLCA, 7-KetoLCA. Finally, mass spectrometry imaging reveals that TCA and TDCA in liver are significantly decreased after hepatocyte PLD1 knockout. These findings demonstrate that hepatocyte PLD1 knockout alters gut microbiota and bile acids profiles, suggesting PLD1 deficiency may modulate MASLD progression by changing intestinal microbiota-bile acid homeostasis. HighlightsHere, we show that hepatocyte PLD1 knockout alters gut microbiota and bile acid profiles in metabolic fatty liver disease mouse by high-fat diet. O_LIWild type (Con) and hepatocyte PLD1 knockout (Con_KO) mice were used to establish HFHC and HFHC_KO models, respectively. C_LIO_LIIntestinal contents were collected for metagenomic and metabolomics analysis, and liver tissues were taken for mass spectrometry imaging to investigate gut microbiota-bile acid relationships. C_LIO_LIIn HFHC_KO mice, Desulfovibrionaceae bacterium LT0009 and Lachnospiraceae bacterium 10-1 were significantly reduced, accompanied by altered HDCA and GLCA. C_LIO_LIAssociation analysis revealed Faecalibaculum co-occurred with DCA, {beta}MCA, {Omega}MCA, and MCA, while Bacteroides uniformis was significantly associated with UDCA, 12-KetoLCA, and 7-KetoLCA. C_LIO_LIMass spectrometry imaging showed hepatocyte PLD1 knockout significantly decreased liver TCA and TDCA, suggesting PLD1 deficiency may modulates MASLD progression via microbiota-bile acid homeostasis. C_LI O_FIG O_LINKSMALLFIG WIDTH=199 HEIGHT=200 SRC="FIGDIR/small/663496v1_ufig1.gif" ALT="Figure 1"> View larger version (36K): org.highwire.dtl.DTLVardef@1b5bfa8org.highwire.dtl.DTLVardef@139ed05org.highwire.dtl.DTLVardef@1f7e905org.highwire.dtl.DTLVardef@e34b59_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: mouse
- assay: metagenomics
- assay: metabolomics
- assay: imaging
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 2
- FWCI
- 0.60
- Field percentile
- top 36%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Host Enzyme Reduces Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Inactivating Intestinal Lipopolysaccharide
Zhiyan Wang, Nore Ojogun, … Mingfang Lu·eLifePeer-reviewed·Oct 14, 2024
- Metabolomic, Lipidomic, and Enterohormone Changes in the Progression from MASLD to MASH
Jaclyn A. Rivas, Alexandria C. Murphy, … Eliseo F. Castillo·MetabolismPeer-reviewed·May 20, 2026
- Hydroxysteroid 17-beta dehydrogenase 13 (Hsd17b13) knockdown attenuates liver steatosis in high-fat diet obese mice
S. Mahmood, N. Z. Morrice, … N. Mody·bioRxiv·Feb 27, 2024
- Integrated Metagenomics and Metabolomics Studies Reveal Core Bacterial Guild Regulating Carbohydrate Metabolism in Pediatric MASLD
Jiating Huang, Xuelian Zhou, … Yan Ni·bioRxiv·May 11, 2026
- Liver microbiome composition associates with histological severity and PNPLA3 genotype in metabolic dysfunction-associated steatotic liver disease
María Florencia Mascardi, R. Taussig, … Julieta Trinks·bioRxiv·Jul 1, 2026
- Gut microbial phenylalanine metabolism contributes to MASLD in a dietary protein-dependent manner
Yi Rou Bah, Dayang Nurul Asyiqin Binte Mustafa, … Kazuyuki Kasahara·bioRxiv·Sep 28, 2026